JP2003128673A5 - - Google Patents

Download PDF

Info

Publication number
JP2003128673A5
JP2003128673A5 JP2002224638A JP2002224638A JP2003128673A5 JP 2003128673 A5 JP2003128673 A5 JP 2003128673A5 JP 2002224638 A JP2002224638 A JP 2002224638A JP 2002224638 A JP2002224638 A JP 2002224638A JP 2003128673 A5 JP2003128673 A5 JP 2003128673A5
Authority
JP
Japan
Prior art keywords
het
alkyl
aryl
substituted
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002224638A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003128673A (ja
Filing date
Publication date
Priority claimed from GBGB9924020.2A external-priority patent/GB9924020D0/en
Application filed filed Critical
Publication of JP2003128673A publication Critical patent/JP2003128673A/ja
Publication of JP2003128673A5 publication Critical patent/JP2003128673A5/ja
Withdrawn legal-status Critical Current

Links

JP2002224638A 1999-10-11 2002-08-01 医薬として活性のある化合物 Withdrawn JP2003128673A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924020.2A GB9924020D0 (en) 1999-10-11 1999-10-11 Pharmaceutically active compounds
GB9924020.2 1999-10-11

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000310665A Division JP3727525B2 (ja) 1999-10-11 2000-10-11 医薬として活性のある化合物

Publications (2)

Publication Number Publication Date
JP2003128673A JP2003128673A (ja) 2003-05-08
JP2003128673A5 true JP2003128673A5 (cg-RX-API-DMAC10.html) 2004-08-26

Family

ID=10862516

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000310665A Expired - Fee Related JP3727525B2 (ja) 1999-10-11 2000-10-11 医薬として活性のある化合物
JP2002224638A Withdrawn JP2003128673A (ja) 1999-10-11 2002-08-01 医薬として活性のある化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000310665A Expired - Fee Related JP3727525B2 (ja) 1999-10-11 2000-10-11 医薬として活性のある化合物

Country Status (7)

Country Link
US (3) US6440982B1 (cg-RX-API-DMAC10.html)
EP (1) EP1092718A1 (cg-RX-API-DMAC10.html)
JP (2) JP3727525B2 (cg-RX-API-DMAC10.html)
BR (1) BR0004786A (cg-RX-API-DMAC10.html)
CA (1) CA2322900C (cg-RX-API-DMAC10.html)
GB (1) GB9924020D0 (cg-RX-API-DMAC10.html)
MX (1) MXPA00009938A (cg-RX-API-DMAC10.html)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6946456B2 (en) * 2000-07-28 2005-09-20 Sloan-Kettering Institute For Cancer Research Methods for treating cell proliferative disorders and viral infections
US6548508B2 (en) 2000-10-20 2003-04-15 Pfizer, Inc. Use of PDE V inhibitors for improved fecundity in mammals
US7439359B2 (en) * 2000-11-02 2008-10-21 Sloan-Kettering Institute For Cancer Research Small molecule compositions for binding to hsp90
US7825094B2 (en) * 2001-05-23 2010-11-02 Sloan-Kettering Institute For Cancer Research Method of treatment for cancers associated with elevated HER 2 levels
WO2003039530A1 (en) * 2001-11-07 2003-05-15 Synthon B.V. Tamsulosin tablets
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
US7323462B2 (en) 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
PT1572173E (pt) 2002-12-13 2010-05-10 Warner Lambert Co Ligando alfa-2-delta para tratar sintomas do tracto urinário inferior
US20050048573A1 (en) * 2003-02-03 2005-03-03 Plexxikon, Inc. PDE5A crystal structure and uses
JP4533590B2 (ja) * 2003-02-28 2010-09-01 ファイザー株式会社 脊髄損傷患者における疼痛又は痙性軽減用医薬組成物
CN100374441C (zh) 2003-06-06 2008-03-12 天津倍方科技发展有限公司 二氢吡咯[2，3-d]嘧啶-4-酮衍生物，其制备方法及其制药用途
US20050079548A1 (en) * 2003-07-07 2005-04-14 Plexxikon, Inc. Ligand development using PDE4B crystal structures
US7291640B2 (en) 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
WO2005053695A1 (ja) * 2003-12-04 2005-06-16 Eisai Co., Ltd. 多発性硬化症予防剤または治療剤
EP1708718A1 (en) 2004-01-22 2006-10-11 Pfizer Limited Triazole derivatives which inhibit vasopressin antagonistic activity
EP1734820A4 (en) * 2004-04-16 2008-01-23 Neurogen Corp Imidazopyrrazine, imidazopyridine, and imidazo-pyrimidine as CRF1 receptor ligands
BRPI0608381A2 (pt) * 2005-02-18 2009-12-29 Surface Logix Inc compostos aprimorados farmacocineticamente
JP2008530246A (ja) * 2005-02-18 2008-08-07 サーフェイス ロジックス，インコーポレイティド 機能性残基又は官能基を含む薬物動態学的に改善された化合物、及び上述の化合物を含む医薬組成物の製造方法
JP2008533192A (ja) 2005-03-21 2008-08-21 ファイザー・リミテッド オキシトシンアンタゴニストとしての置換されたトリアゾール誘導体
US20070010525A1 (en) * 2005-06-27 2007-01-11 Meyer Jackson Method and compositions for modulating neuropeptide hormone secretion
CN101747282A (zh) * 2008-12-10 2010-06-23 上海特化医药科技有限公司 一类含有嘧啶酮苯基的化合物、其药物组合物及其制备方法和用途
JP2012513464A (ja) 2008-12-23 2012-06-14 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク ホスホジエステラーゼ阻害剤及びその使用
US12061685B2 (en) 2011-12-30 2024-08-13 Analog Devices, Inc. Image capture devices for a secure industrial control system
US8971072B2 (en) 2011-12-30 2015-03-03 Bedrock Automation Platforms Inc. Electromagnetic connector for an industrial control system
US11314854B2 (en) 2011-12-30 2022-04-26 Bedrock Automation Platforms Inc. Image capture devices for a secure industrial control system
US9437967B2 (en) 2011-12-30 2016-09-06 Bedrock Automation Platforms, Inc. Electromagnetic connector for an industrial control system
US9467297B2 (en) 2013-08-06 2016-10-11 Bedrock Automation Platforms Inc. Industrial control system redundant communications/control modules authentication
US11967839B2 (en) 2011-12-30 2024-04-23 Analog Devices, Inc. Electromagnetic connector for an industrial control system
US10834820B2 (en) 2013-08-06 2020-11-10 Bedrock Automation Platforms Inc. Industrial control system cable
US9191203B2 (en) 2013-08-06 2015-11-17 Bedrock Automation Platforms Inc. Secure industrial control system
US9600434B1 (en) 2011-12-30 2017-03-21 Bedrock Automation Platforms, Inc. Switch fabric having a serial communications interface and a parallel communications interface
US10834094B2 (en) 2013-08-06 2020-11-10 Bedrock Automation Platforms Inc. Operator action authentication in an industrial control system
US8862802B2 (en) 2011-12-30 2014-10-14 Bedrock Automation Platforms Inc. Switch fabric having a serial communications interface and a parallel communications interface
US9727511B2 (en) 2011-12-30 2017-08-08 Bedrock Automation Platforms Inc. Input/output module with multi-channel switching capability
US10613567B2 (en) 2013-08-06 2020-04-07 Bedrock Automation Platforms Inc. Secure power supply for an industrial control system
CN111293495B (zh) 2014-07-07 2022-05-24 基岩自动化平台公司 工业控制系统电缆
US10183949B2 (en) 2014-08-29 2019-01-22 The University Of Tokyo Pyrimidinone derivative having autotaxin-inhibitory activity
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds
GB201909194D0 (en) * 2019-06-26 2019-08-07 Ucb Biopharma Sprl Therapeutic agents

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1972785U (de) 1967-07-26 1967-11-16 August Manss Stapelkarre mit greifereinrichtung.
CA1303037C (en) 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Purinone derivatives as bronchodilators vasodilators and anti-allergic agents
GB8817651D0 (en) 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
GB9013750D0 (en) 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9126260D0 (en) 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
GB9213623D0 (en) 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents
FI951367A7 (fi) 1994-03-28 1995-09-29 Japan Energy Corp Puriinijohdannaiset ja tulehdustautien tukahduttajat (suppressantit)
GB9423911D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
DE19501480A1 (de) 1995-01-19 1996-07-25 Bayer Ag 9-substituierte 2-(2-n-Alkoxyphenyl)-purin-6-one
DE19501482A1 (de) 1995-01-19 1996-07-25 Bayer Ag 2,9-disubstituierte Purin-6-one
DE19702785A1 (de) 1997-01-27 1998-07-30 Bayer Ag Neue cyclische Harnstoffderivate
ES2203078T3 (es) 1998-04-20 2004-04-01 Pfizer Inc. Parazolopirimidinonas inhibidoras de gmpc pde5 para el tratamiento de la disfuncion sexual.
US6124303A (en) 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones

Similar Documents

Publication Publication Date Title
JP2019518050A5 (cg-RX-API-DMAC10.html)
JP2004523585A5 (cg-RX-API-DMAC10.html)
JP2008530099A5 (cg-RX-API-DMAC10.html)
JP2002529532A5 (cg-RX-API-DMAC10.html)
JP2005508960A5 (cg-RX-API-DMAC10.html)
JP2008535831A5 (cg-RX-API-DMAC10.html)
CA2429308A1 (en) Novel lactam-substituted pyrazolopyridine derivatives
JP2008503484A5 (cg-RX-API-DMAC10.html)
JP2008509187A5 (cg-RX-API-DMAC10.html)
JP2005538100A5 (cg-RX-API-DMAC10.html)
JP2005535586A5 (cg-RX-API-DMAC10.html)
JP2005519932A5 (cg-RX-API-DMAC10.html)
JP2005509622A5 (cg-RX-API-DMAC10.html)
JP2005526836A5 (cg-RX-API-DMAC10.html)
CA2474192A1 (en) Nicotinamide derivates useful as p38 inhibitors
JP2002508375A5 (cg-RX-API-DMAC10.html)
JP2005530811A5 (cg-RX-API-DMAC10.html)
JP2007507494A5 (cg-RX-API-DMAC10.html)
CN101945876A (zh) 对慢性疼痛疾病有活性的含氮双环化合物
JP2005538111A5 (cg-RX-API-DMAC10.html)
JP2009533417A5 (cg-RX-API-DMAC10.html)
PH12020550761A1 (en) 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZINONE DERIVATIVE AND MEDICAL USE THEREOF
JP2004525183A5 (cg-RX-API-DMAC10.html)
JP2003507479A5 (cg-RX-API-DMAC10.html)
RU2008119465A (ru) Производные циклопропилуксусной кислоты и их применение